Cyclophosphamide, Vincristine, and Prednisone Followed by Tositumomab and Iodine-131–Tositumomab in Patients With Untreated Low-Grade Follicular Lymphoma: Eight-Year Follow-Up of a Multicenter Phase ...
Immune Checkpoint Inhibitor Outcomes for Patients With Non–Small-Cell Lung Cancer Receiving Baseline Corticosteroids for Palliative Versus Nonpalliative Indications Median time to relapse was 7.4 ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Approximately 20 ...
Doctor showing tablet to patient. A new risk stratification model can identify patients with stage I seminoma who have a high risk of relapse, according to researchers. A new risk stratification model ...
More than half of patients with BRAF-mutated advanced melanoma taking Tafinlar+ Mekinist were alive and free of a relapse at 5- years 1 Study conclusions are drawn from the largest dataset and longest ...
Breast cancer survivors must remain vigilant for recurrence signs, which can manifest locally, regionally, or distantly. New ...
FRANKFURT, Germany--(BUSINESS WIRE)--NeraCare, a leading developer of laboratory tests for personalized survival prediction of melanoma patients, today announced publication of an abstract describing ...
This is a preview. Log in through your library . Abstract Purpose This study aims to investigate the factors that influence the risk of metastatic relapse in women presenting with stage I-III breast ...
Recurrent Hodgkin lymphoma means the cancer returns after treatment and remission. In many cases, further treatments can help achieve remission or a possible cure. Hodgkin lymphoma (HL) is a type of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback